Gründer und CEO Themis Bioscience
Dr. Erich Tauber
Dr. Erich Tauber, MD, co-founded Themis in 2009 to build a biotech company that bridges the gap between ground-breaking science and industrial excellence in immune system modulation. He held the position of Themis’ CEO until its acquisition by MSD (trademark of Merck & Co., Inc., Kenilworth, N.J., USA) in June 2020 and continues to lead the Themis team as part of the larger organization. Before building Themis into a world-class vaccine discovery and development organization, he served in various roles with increasing responsibility at AstraZeneca, Baxter, Intercell and Nycomed. Over the course of his career, he was responsible for the development and commercialization of numerous therapies and vaccines and continues to be a renowned expert in the field of vaccine development as well as a frequent author of scientific publications. He received his medical training at the University of Vienna and holds a Medical Doctorate from the Medical University in Vienna.